These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
320 related articles for article (PubMed ID: 36672482)
1. Hepatitis Virus and Hepatocellular Carcinoma: Recent Advances. Shen C; Jiang X; Li M; Luo Y Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672482 [TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma. D'souza S; Lau KC; Coffin CS; Patel TR World J Gastroenterol; 2020 Oct; 26(38):5759-5783. PubMed ID: 33132633 [TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma and infections with multiple hepatitis viruses. Brunetto MR; Oliveri F; Colombatto P; Bonino F Princess Takamatsu Symp; 1995; 25():61-6. PubMed ID: 8875610 [TBL] [Abstract][Full Text] [Related]
4. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China. Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109 [TBL] [Abstract][Full Text] [Related]
5. Molecular Signature and Mechanisms of Hepatitis D Virus-Associated Hepatocellular Carcinoma. Diaz G; Engle RE; Tice A; Melis M; Montenegro S; Rodriguez-Canales J; Hanson J; Emmert-Buck MR; Bock KW; Moore IN; Zamboni F; Govindarajan S; Kleiner DE; Farci P Mol Cancer Res; 2018 Sep; 16(9):1406-1419. PubMed ID: 29858376 [TBL] [Abstract][Full Text] [Related]
6. Virus associated malignancies: the role of viral hepatitis in hepatocellular carcinoma. Shlomai A; de Jong YP; Rice CM Semin Cancer Biol; 2014 Jun; 26():78-88. PubMed ID: 24457013 [TBL] [Abstract][Full Text] [Related]
7. Hepatocellular carcinoma in Egyptians with and without a history of hepatitis B virus infection: association with hepatitis C virus (HCV) infection but not with (HCV) RNA level. Yates SC; Hafez M; Beld M; Lukashov VV; Hassan Z; Carboni G; Khaled H; McMorrow M; Attia M; Goudsmit J Am J Trop Med Hyg; 1999 Apr; 60(4):714-20. PubMed ID: 10348253 [TBL] [Abstract][Full Text] [Related]
8. Risk of hepatocellular carcinoma in hepatitis B and D virus co-infected patients: A systematic review and meta-analysis of longitudinal studies. Kamal H; Fornes R; Simin J; Stål P; Duberg AS; Brusselaers N; Aleman S J Viral Hepat; 2021 Oct; 28(10):1431-1442. PubMed ID: 34291520 [TBL] [Abstract][Full Text] [Related]
9. Incidence of hepatocellular carcinoma in a community-based Taiwanese population without chronic HBV/HCV infection. Wu HC; Jeng WJ; Pan MH; Hsieh YC; Lu SN; Chen CJ; Yang HI JHEP Rep; 2022 Feb; 4(2):100410. PubMed ID: 35079699 [TBL] [Abstract][Full Text] [Related]
10. Hepatitis D Virus and Hepatocellular Carcinoma. Farci P; Niro GA; Zamboni F; Diaz G Viruses; 2021 May; 13(5):. PubMed ID: 34064419 [TBL] [Abstract][Full Text] [Related]
11. Somatic mutations, viral integration and epigenetic modification in the evolution of hepatitis B virus-induced hepatocellular carcinoma. Ji X; Zhang Q; Du Y; Liu W; Li Z; Hou X; Cao G Curr Genomics; 2014 Dec; 15(6):469-80. PubMed ID: 25646075 [TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic characteristics andoutcomes of hepatocellular carcinoma associated with chronic hepatitis B versus hepatitis C infection. Aljumah AA; Kuriry H; Faisal N; Alghamdi H Ann Saudi Med; 2018; 38(5):358-365. PubMed ID: 30284991 [TBL] [Abstract][Full Text] [Related]
13. Hepatitis C Virus Mediated Metastasis in Hepatocellular Carcinoma as a Therapeutic Target for Cancer Management. Khera L; Paul C; Kaul R Curr Drug Metab; 2018; 19(3):224-235. PubMed ID: 29380693 [TBL] [Abstract][Full Text] [Related]
14. Hepatitis B/D-Related Hepatocellular Carcinoma. A Clinical Literature Review. Baskiran A; Atay A; Baskiran DY; Akbulut S J Gastrointest Cancer; 2021 Dec; 52(4):1192-1197. PubMed ID: 34611832 [TBL] [Abstract][Full Text] [Related]
15. Blood-Based Biomarkers in Hepatitis B Virus-Related Hepatocellular Carcinoma, Including the Viral Genome and Glycosylated Proteins. Hayashi S; Nagaoka K; Tanaka Y Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681709 [TBL] [Abstract][Full Text] [Related]
16. HBV induced hepatocellular carcinoma and related potential immunotherapy. Jia L; Gao Y; He Y; Hooper JD; Yang P Pharmacol Res; 2020 Sep; 159():104992. PubMed ID: 32505833 [TBL] [Abstract][Full Text] [Related]
17. Reduced Expression of DNA Damage Repair Genes High Mobility Group Box1 and Poly(ADP-ribose) Polymerase1 in Inactive Carriers of Hepatitis B Virus Infection-A Possible Stage of Viral Integration. Mukherjee RM; Shravanti GV; Jakkampudi A; Kota R; Jangala AL; Reddy PB; Rao PN; Gupta R; Reddy DN J Clin Exp Hepatol; 2013 Jun; 3(2):89-95. PubMed ID: 25755481 [TBL] [Abstract][Full Text] [Related]
18. MicroRNAs as therapeutic strategy for hepatitis B virus-associated hepatocellular carcinoma: current status and future prospects. Tan YL; Chen WN World J Gastroenterol; 2014 May; 20(20):5973-86. PubMed ID: 24876720 [TBL] [Abstract][Full Text] [Related]